Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Working together, these hormones keep blood sugar in check, slow the movement of food through the gut and signal the brain about fullness, which helps manage appetite and food intake.
❓ Unknown
Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports
Just now
November 17, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
This article discusses Tirzepatide (Zepbound), a new obesity treatment medication that has shown clinical success in moving over half of treated teenagers below the obesity threshold. The article is not related to Iran and contains no information about Iranian affairs, politics, economy, military, human rights, or international relations.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Davoud Rokhbin Executed for Murder in Kashan Prison
Just now •
Ali Mokhtari Executed for Rape in Shahre Kord
20 min ago •
New theoretical framework free of ghostlike instabilities expands the possibilities of symmetry in particle physics
20 min ago •
Genetic 'dimmer switch' that can boost sepsis resistance discovered
30 min ago •